Статья
Clinton Foundation Reaches Deal With Matrix, Pfizer To Cut Prices For Second-Line ARVs, TB Drug
Former President Bill Clinton on Thursday announced deals with drugmakers Matrix Laboratories [part of Mylan] and Pfizer to lower the cost of medications to treat patients with drug-resistant HIV in the developing world…the 2010 cost for the four drugs "is 28 percent lower than the current lowest-priced alternative"…Matrix will also "make ritonavir available in a heat-stable version more suitable for tropical climates"…